The largest database of trusted experimental protocols

Rapamycin is a macrolide compound isolated from the bacterium Streptomyces hygroscopicus. It functions as an immunosuppressant and has applications in various fields of research, including cell biology, biochemistry, and pharmacology.

Automatically generated - may contain errors

4 protocols using rapamycin

1

Quantifying Sch9 Phosphorylation in Yeast

Check if the same lab product or an alternative is used in the 5 most similar protocols
A plasmid expressing Sch9 under the ADH1 promoter (pJG1288) was made by amplifying Sch9-HIS using primers JG3330 and JG3331 and cloning into pJG1285. This Sch9 plasmid was transformed into yeast (WT [JGY1], reg1 [JGY95], snf1 [JGY91], reg1psk1psk2 [JGY283], reg1snf1psk1psk2 [JGY280]), grown in SD-Trp overnight, and then diluted 1:100 into YPAD and grown until OD600 ∼1.0. For rapamycin controls, 100 nM rapamycin (Research Products International, Mount Prospect, IL) was added 1 h before harvesting cells. Preparation of Sch9 protein extract was performed as described by Miller-Fleming et al. (2014) (link). Samples were normalized and loaded on 8% SDS–PAGE, transferred to nitrocellulose membrane, and incubated overnight with anti–phospho-Thr737-Sch9 and anti–Thr737-Sch9 antibodies (Kingsbury et al., 2014 (link)). Intensity signals were quantified using ImageJ (National Institutes of Health, Bethesda, MD).
+ Open protocol
+ Expand
2

CRISPR-based Point Mutation Introduction

Check if the same lab product or an alternative is used in the 5 most similar protocols
For editing of diverse genomic loci, HEK293T cells (lacking the single copy d2gfp) were used and maintained as above. The transfection protocol was performed as described above, with the exception that different sgRNAs were used for targeting of other loci. In each case, the sgRNAs expose a window where base editing can result in the introduction of point mutations in DNA modifying enzymes that lead to either missense or nonsense mutations. As with the d2GFP editing assay, 24 hours after transfection, rapamycin (Research Products International) was added to select wells at a final concentration of 200 nM. This concentration was continuously maintained until the end of the experiment. Transfected cells were harvested at day 3 after transfection, ensuring single-cell suspension. Genomic DNA was collected using the DNeasy Blood & Tissue Kit (Qiagen) according to manufacturer’s instructions for sequencing analysis as described in the “DNA library preparation and sequencing” section below.
+ Open protocol
+ Expand
3

Cellular Reagents and Inhibitors Database

Check if the same lab product or an alternative is used in the 5 most similar protocols
Farnesyltransferase inhibitor was obtained from Enzo Life Sciences (Farmingdale, NY) and geranylgeranyltransferase I inhibitor was from Tocris Biosciences (Bristol, UK). Horse serum and penicillin-streptomycin were from Life Technologies, Alexa Fluor 488 phalloidin and lipofectamine RNAiMAX transfection reagent were from Invitrogen, and EGF was from PeproTech, at Thermo Fisher Scientific (Waltham, MA). Hygromycin B and ProBlock gold protease inhibitor cocktail were obtained from Gold Biotechnology (St-Louis, MI). DMEM, DMEM/F12, RPMI-1640, and McCoy’s 5A media were from Corning (Corning, NY). Rapamycin was from Research Products International (Mount Prospect, IL); Torin2 was from ApexBio (Houston, TX); fetal bovine serum (FBS) was from Avantor (Radnor Township, PA); hydrocortisone was from United States Pharmacopeia (Rockville, MD); cholera toxin was from List Biological Laboratories (Campbell, CA); puromycin was from Mirus Bio LLC (Madison, WI); and insulin was from Sigma-Aldrich (St. Louis, MO).
+ Open protocol
+ Expand
4

Examining Ras Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Life Technologies Penicillin-Streptomycin, Life Technologies OptiMEM I Reduced Serum Medium, Invitrogen Lipofectamine RNAiMAX Transfection reagent, PeproTech Animal-free Recombinant Human EGF, Invitrogen MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-Diphenyltetrosolium), and Corning RPMI 1640 Medium (Mod. w/o phenol red) 1X without glutamine, were purchased from Thermo Fisher Scientific (Waltham, MA). Fetal bovine serum (FBS) and PP242 were obtained from Avantor (Radnor Township, PA); RPMI-1640 media was purchased from Corning (Corning, NY); Rapamycin was obtained from Research Products International (Mt. Prospect, IL); and ProBlock Gold Protease Inhibitor Cocktail was from Gold Biotechnology (St. Louis, MI). Dharmacon ON-TARGETplus Non-targeting siRNA Control Pool and SMARTPool of Human H-Ras (3265), Human N-Ras (4893), and Human K-Ras (3845) were obtained from Horizon Discovery (Waterbeach, UK), and SignalSilence Control siRNA (unconjugated) and SignalSilence Rictor siRNA were purchased from Cell Signaling Technology (Danvers, MA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!